Withdrawn

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

JPCX - ClinicalTrials.gov - NCT03988114

The reason for this study is to see if the drug abemaciclib in combination with nonsteroidal aromatase inhibitors (anastrozole or letrozole) is effective in participants with Hormone Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) advanced breast cancer that have certain disease characteristics.
How long will I be in the trial?
Your participation in this trial could last up to 20 months, depending on your cancer type and how you and your tumor respond
Email
Withdrawn

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

JPCX - ClinicalTrials.gov - NCT03988114

The reason for this study is to see if the drug abemaciclib in combination with nonsteroidal aromatase inhibitors (anastrozole or letrozole) is effective in participants with Hormone Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) advanced breast cancer that have certain disease characteristics.
How long will I be in the trial?
Your participation in this trial could last up to 20 months, depending on your cancer type and how you and your tumor respond
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Metastatic Breast Cancer, Solid Tumor

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

650

Trial Dates

September 2019 - March 2023

Trial Phase

4

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Metastatic Breast Cancer, Solid Tumor

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

650

Trial Dates

September 2019 - March 2023

Trial Phase

4

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?